Status
Conditions
About
Mediastinitis are rare but serious infections, with mortality rates varying from 6 to 30% according to the literature. They are essentially linked to surgical management (cardio-thoracic in particular), but some forms can be spontaneous, after extension of an ENT infectious focus, for example.
Despite their seriousness, there is no strong recommendations to define their management, especially concerning antibiotic therapy and its duration.
The aim of this research is to make a descriptive analysis of the cases of mediastinitis at HUS in recent years, and to study the therapeutic strategy used
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Yvon RUCH, MD; Saïd CHAYER, PhD, HDR
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal